Filtros de búsqueda

Lista de obras de Jason Grebely

'I didn't want to let it go too far.' The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study.

artículo científico publicado en 2017

6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection—What are the remaining gaps?

article

A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs – do gender differences vary by country-level indicators?

artículo científico publicado en 2019

A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015

article

A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events

artículo científico publicado en 2015

A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies

artículo científico publicado en 2016

A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses

artículo científico publicado en 2014

A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspective

artículo científico publicado en 2005

A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections

scientific article published on 14 January 2019

Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia

article

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

artículo científico publicado en 2019

Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials

artículo científico publicado en 2019

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

artículo científico publicado en 2017

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users ⬇️

artículo científico publicado el 23 de noviembre de 2010

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection

artículo científico publicado en 2016

An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community ⬇️

artículo científico publicado el 1 de diciembre de 2011

An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study

scientific article published on 11 July 2019

Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation

artículo científico publicado en 2020

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?

artículo científico publicado en 2015

Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study ⬇️

artículo científico publicado el 1 de agosto de 2013

Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia

artículo científico

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model

scientific article published on 01 May 2020

Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis

scientific article published on 24 May 2020

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis

artículo científico publicado en 2020

Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia

article

Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada

artículo científico publicado en 2019

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

artículo científico publicado en 2020

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

article

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists-The practitioner experience

artículo científico publicado en 2019

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.

artículo científico publicado en 2007

Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review

artículo científico publicado en 2011

Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels ⬇️

artículo científico publicado el 1 de marzo de 2013

COVID-19 and the health of people who use drugs: What is and what could be?

artículo científico publicado en 2020

Can hepatitis C virus infection be eradicated in people who inject drugs?

artículo científico

Case definitions for acute hepatitis C virus infection: a systematic review.

artículo científico

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

artículo científico publicado en 2017

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

artículo científico publicado en 2022

Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment

artículo científico publicado en 2016

Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.

artículo científico publicado en 2013

Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapy

scientific article published on 20 August 2007

Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.

artículo científico publicado en 2012

Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?

scientific article published on 09 August 2018

Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents.

artículo científico publicado en 2013

Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.

artículo científico publicado en 2017

Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C

artículo científico publicado en 2020

Current approaches to HCV infection in current and former injection drug users

artículo científico publicado en 2008

Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia

article

Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.

artículo científico publicado en 2014

Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing

artículo científico publicado en 2016

Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs

artículo científico

Delivery of treatment for hepatitis C virus infection in the primary care setting

artículo científico publicado en 2014

Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia.

artículo científico publicado en 2016

Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis

artículo científico publicado en 2019

Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimation

artículo científico publicado en 2015

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

artículo científico publicado en 2017

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

scholarly article by Behzad Hajarizadeh et al published November 2018 in The lancet. Gastroenterology & hepatology

Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada

scientific article published on 06 June 2019

Direct-acting antivirals for acute HCV: how short can we go?

artículo científico publicado en 2017

Directly Observed Pegylated Interferon Plus Self-Administered Ribavirin for the Treatment of Hepatitis C Virus Infection in People Actively Using Drugs: A Randomized Controlled Trial ⬇️

artículo científico publicado el 1 de agosto de 2013

Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users

artículo científico publicado en 2007

Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?

artículo científico publicado en 2014

Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection ⬇️

artículo científico publicado en 2021

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach

artículo científico publicado en 2017

Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment.

scientific article published on 31 January 2017

Dynamics of HCV RNA levels during acute hepatitis C virus infection

artículo científico publicado en 2014

Effect of pegylated interferon‐α‐2a treatment on mental health during recent hepatitis C virus infection ⬇️

artículo científico publicado el 1 de mayo de 2012

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

artículo científico publicado en 2010

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

artículo científico publicado en 2016

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

artículo científico publicado en 2016

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study

artículo científico publicado en 2017

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial

artículo científico publicado en 2020

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.

artículo científico publicado en 2016

Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?

artículo científico publicado en 2017

Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy

artículo científico publicado en 2017

Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements

artículo científico

Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all

artículo científico publicado en 2019

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

artículo científico publicado en 2015

Epidemiology and natural history of HCV infection.

artículo científico

Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort study

scientific article published on 30 March 2020

Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia

artículo científico publicado en 2017

Estimating the number of people who inject drugs in Australia

artículo científico publicado en 2017

Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples

scientific article published on 26 June 2018

Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study

scientific article published on 18 September 2019

Evaluation of the Aptima HCV Quant Dx Assay for HCV RNA detection from finger-stick capillary dried blood spot and venepuncture-collected samples

artículo científico publicado en 2020

Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study

artículo científico publicado en 2017

Evaluation of the Xpert® HCV Viral Load Fingerstick point-of-care assay

artículo científico publicado en 2018

Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia

artículo científico publicado en 2015

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data? ⬇️

artículo científico publicado en 2015

Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs.

artículo científico publicado en 2015

Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs ⬇️

artículo científico publicado el 30 de diciembre de 2010

Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users

artículo científico publicado en 2007

Frequency of injecting among people who inject drugs: A systematic review and meta-analysis

artículo científico publicado en 2019

Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn.

artículo científico publicado en 2014

Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing

scientific article published on 08 March 2019

Genomic variability of within-host hepatitis C variants in acute infection

scientific article published on 22 January 2019

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration

article published in 2017

Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies

artículo científico publicado en 2018

Global elimination of hepatitis C virus by 2030: why not?

artículo científico publicado en 2020

Global patterns of opioid use and dependence: harms to populations, interventions, and future action

artículo científico publicado en 2019

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

artículo científico publicado en 2017

Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

article

Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence

artículo científico publicado en 2020

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

artículo científico publicado en 2017

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

artículo científico publicado en 2018

HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs

artículo científico publicado en 2017

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection

artículo científico publicado en 2016

HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype

artículo científico publicado en 2017

HCV reinfection studies and the door to vaccine development

artículo científico publicado en 2009

HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.

artículo científico publicado en 2015

HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection

artículo científico publicado en 2016

Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study

artículo científico publicado en 2015

Hepatitis C Virus Treatment and Persons Who Inject Drugs

scientific article published on 01 February 2016

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

article published in 2018

Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis

artículo científico publicado en 2017

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

scientific article published on 27 November 2019

Hepatitis C treatment as prevention: evidence, feasibility, and challenges

artículo científico publicado en 2016

Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system ⬇️

artículo científico publicado en 2021

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

artículo científico publicado en 2012

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

artículo científico publicado en 2017

Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs

artículo científico publicado en 2012

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection

artículo científico publicado en 2012

Hepatitis C virus reinfection in injection drug users

artículo científico publicado en 2006

Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study

article

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study

artículo científico publicado en 2019

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

artículo científico publicado en 2013

Hepatitis C: Enhancing treatment for hepatitis C among drug users

artículo científico publicado en 2010

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

artículo científico publicado en 2017

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia

scientific article published on 12 September 2020

High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.

artículo científico publicado en 2013

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan

artículo científico publicado en 2016

Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia

artículo científico publicado en 2016

Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.

artículo científico publicado en 2011

Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada ⬇️

artículo científico publicado en 2021

Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis

artículo científico publicado en 2020

Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

artículo científico publicado en 2015

Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative

artículo científico publicado en 2016

Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study

artículo científico publicado en 2014

Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types.

artículo científico publicado en 2015

Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations

artículo científico publicado en 2008

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review.

artículo científico

Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs ⬇️

artículo científico publicado el 21 de mayo de 2012

Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection

artículo científico publicado en 2017

Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study

artículo científico publicado en 2018

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

artículo científico publicado en 2009

Management of HCV and HIV infections among people who inject drugs ⬇️

artículo científico publicado el 1 de noviembre de 2011

Management of acute HCV infection in the era of direct-acting antiviral therapy

artículo científico publicado en 2018

Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data

artículo científico publicado en 2015

Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection

artículo científico publicado en 2016

Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program

artículo científico publicado en 2007

Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada

artículo científico publicado en 2015

Mixed HCV infection and reinfection in people who inject drugs--impact on therapy

artículo científico

Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis ⬇️

artículo científico publicado en 2021

Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling study

scientific article published on 30 August 2019

Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada

artículo científico publicado en 2013

Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.

artículo científico publicado en 2018

Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs.

artículo científico publicado en 2013

Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C.

artículo científico publicado en 2014

Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030

scientific article published on 12 April 2017

New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction series

artículo científico publicado en 2017

Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic

artículo científico publicado en 2020

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study

artículo científico publicado en 2020

Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study

artículo científico

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support

artículo científico publicado en 2010

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international

scientific article published on 11 July 2019

Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study

artículo científico publicado en 2015

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study

scientific article published on 11 June 2019

Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting

artículo científico publicado en 2020

Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study

artículo científico publicado en 2018

Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia

artículo científico publicado en 2019

Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: Findings from a cross-sectional study in three Australian cities

artículo científico publicado en 2020

Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spots

artículo científico publicado en 2019

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

artículo científico publicado en 2013

Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection

artículo científico publicado en 2013

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

artículo científico publicado en 2010

Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis

artículo científico publicado en 2019

Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada

artículo científico publicado en 2019

Prevention of Hepatitis C Virus in Injecting Drug Users: A Narrow Window of Opportunity ⬇️

artículo científico publicado el 31 de enero de 2011

Prevention, treatment and care of hepatitis C virus infection among people who inject drugs

artículo científico publicado en 2014

Primary drug resistance in antiretroviral-naïve injection drug users

artículo científico publicado en 2008

Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs

artículo científico publicado en 2019

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

artículo científico publicado en 2016

Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study

scientific article published on 18 May 2020

Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort

artículo científico publicado en 2016

Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral

Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection

artículo científico publicado en 2015

Recommendations for the management of hepatitis C virus infection among people who inject drugs

artículo científico publicado en 2015

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

artículo científico publicado en 2013

Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs

scientific article published on 12 March 2020

Reinfection with hepatitis C virus following sustained virological response in injection drug users

artículo científico publicado en 2010

Reply:

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

artículo científico publicado en 2017

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

artículo científico publicado en 2015

Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study

artículo científico publicado en 2016

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

artículo científico publicado en 2017

Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy

artículo científico publicado en 2019

Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review.

artículo científico publicado en 2017

Sequencing of the Hepatitis C Virus: A Systematic Review.

artículo científico publicado en 2013

Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection

artículo científico publicado en 2020

Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada

article

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies

artículo científico publicado en 2016

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies.

artículo científico publicado en 2016

Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection

artículo científico publicado en 2019

Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review

scientific article published on 06 February 2020

Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study

artículo científico publicado en 2016

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

artículo científico publicado en 2018

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

artículo científico publicado en 2018

Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs

artículo científico publicado en 2015

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs

artículo científico publicado en 2018

Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014).

artículo científico publicado en 2017

The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era.

artículo científico publicado en 2014

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.

artículo científico publicado en 2016

The 7th Canadian Symposium on Hepatitis C Virus: “Toward Elimination of HCV: How to Get There”

article

The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination

artículo científico publicado en 2019

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

artículo científico publicado en 2015

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC) ⬇️

artículo científico publicado en 2016

The Second Canadian Symposium on hepatitis C virus: a call to action

artículo científico publicado en 2013

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study

artículo científico publicado en 2017

The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

article

The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative.

artículo científico publicado en 2017

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study

artículo científico publicado en 2015

The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males.

artículo científico publicado en 2016

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

artículo científico publicado en 2013

The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users

artículo científico publicado en 2014

The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program

scientific article published on 23 March 2007

The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design

artículo científico publicado en 2012

The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis

artículo científico publicado en 2019

The removal of DAA restrictions in Europe – One step closer to eliminating HCV as a major public health threat

article

The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges? ⬇️

artículo científico publicado en 2018

The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure

artículo científico publicado en 2008

Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study

artículo científico publicado en 2016

Time to detection of hepatitis C virus infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a more rapid time to diagnosis

scientific article published on 29 January 2020

Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada

artículo científico publicado en 2016

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study

artículo científico publicado en 2015

Treatment of acute HCV infection ⬇️

artículo científico publicado el 22 de marzo de 2011

Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

artículo científico

Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection

artículo científico

Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).

artículo científico publicado en 2016

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison

artículo científico publicado en 2017

Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment

artículo científico publicado en 2014

Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison

artículo científico publicado en 2018

Uptake of direct acting antiviral treatment for chronic hepatitis C in Australia

artículo científico publicado en 2017

Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection

artículo científico publicado en 2012

What Is Killing People with Hepatitis C Virus Infection? ⬇️

artículo científico publicado el 21 de diciembre de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda